Cathay Biotech Inc.
688065.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CN¥142 | CN¥0 | CN¥137 | CN¥0 |
| Dep. & Amort. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Deferred Tax | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Change in WC | CN¥0 | -CN¥196 | CN¥0 | CN¥0 |
| Other Non-Cash | -CN¥208 | CN¥448 | -CN¥49 | CN¥145 |
| Operating Cash Flow | -CN¥66 | CN¥252 | CN¥87 | CN¥145 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥188 | -CN¥79 | -CN¥280 | -CN¥199 |
| Net Acquisitions | CN¥25 | CN¥0 | CN¥0 | CN¥0 |
| Inv. Purchases | CN¥1,500 | -CN¥1,500 | -CN¥26 | CN¥0 |
| Inv. Sales/Matur. | -CN¥400 | CN¥400 | CN¥0 | CN¥0 |
| Other Inv. Act. | -CN¥906 | CN¥10 | CN¥0 | -CN¥10 |
| Investing Cash Flow | CN¥31 | -CN¥1,168 | -CN¥305 | -CN¥209 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -CN¥276 | -CN¥1,079 | -CN¥237 | CN¥585 |
| Stock Issued | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock Repurch. | CN¥1 | -CN¥1 | CN¥0 | CN¥0 |
| Dividends Paid | CN¥0 | -CN¥2 | -CN¥13 | -CN¥11 |
| Other Fin. Act. | -CN¥289 | CN¥52 | CN¥5,915 | -CN¥10 |
| Financing Cash Flow | -CN¥564 | -CN¥1,029 | CN¥5,665 | CN¥563 |
| Forex Effect | -CN¥14 | -CN¥6 | CN¥2 | CN¥53 |
| Net Chg. in Cash | -CN¥614 | -CN¥1,952 | CN¥5,450 | CN¥552 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥8,720 | CN¥10,636 | CN¥5,186 | CN¥4,634 |
| End Cash | CN¥8,106 | CN¥8,684 | CN¥10,636 | CN¥5,186 |
| Free Cash Flow | -CN¥254 | CN¥173 | -CN¥192 | -CN¥54 |